Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial

Hdl Handle:
http://hdl.handle.net/10144/618956
Title:
Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial
Authors:
Coldiron, M; Alcoba, G; Ciglenecki, I; Hitchings, M; Djibo, A; Page, A; Langendorf, C; Grais, R
Journal:
Trials
Abstract:
Epidemics of meningococcal meningitis are common in the "African meningitis belt." Current response strategies include reactive vaccination campaigns, which are often organized too late to have maximal impact. A novel strain of Neisseria meningitidis serogroup C has been circulating in recent years, and vaccine supplies are limited. An evaluation of chemoprophylaxis with single-dose ciprofloxacin for household contacts of meningitis cases has therefore been recommended.
Publisher:
BioMed Central
Issue Date:
24-Jun-2017
URI:
http://hdl.handle.net/10144/618956
DOI:
10.1186/s13063-017-2028-y
PubMed ID:
28646924
Submitted date:
2017-07-06
Language:
en
ISSN:
1745-6215
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorColdiron, Men
dc.contributor.authorAlcoba, Gen
dc.contributor.authorCiglenecki, Ien
dc.contributor.authorHitchings, Men
dc.contributor.authorDjibo, Aen
dc.contributor.authorPage, Aen
dc.contributor.authorLangendorf, Cen
dc.contributor.authorGrais, Ren
dc.date.accessioned2017-07-06T18:06:13Z-
dc.date.available2017-07-06T18:06:13Z-
dc.date.issued2017-06-24-
dc.date.submitted2017-07-06-
dc.identifier.citationCiprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trial. 2017, 18 (1):294 Trialsen
dc.identifier.issn1745-6215-
dc.identifier.pmid28646924-
dc.identifier.doi10.1186/s13063-017-2028-y-
dc.identifier.urihttp://hdl.handle.net/10144/618956-
dc.description.abstractEpidemics of meningococcal meningitis are common in the "African meningitis belt." Current response strategies include reactive vaccination campaigns, which are often organized too late to have maximal impact. A novel strain of Neisseria meningitidis serogroup C has been circulating in recent years, and vaccine supplies are limited. An evaluation of chemoprophylaxis with single-dose ciprofloxacin for household contacts of meningitis cases has therefore been recommended.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsArchived with thanks to Trialsen
dc.titleCiprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response: Study Protocol for a Cluster-Randomized Trialen
dc.identifier.journalTrialsen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.